XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
242 hedge funds and large institutions have $4.6B invested in Acceleron Pharma in 2020 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $4.32B → $4.6B (+$276M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
242
Holding in Top 10
5
Calls
$58.6M
Puts
$51.5M
Top Buyers
| 1 | +$61.4M | |
| 2 | +$28.3M | |
| 3 | +$26.6M | |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$24.7M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$24.4M |
Top Sellers
| 1 | -$65.1M | |
| 2 | -$45.5M | |
| 3 | -$37.7M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$33.2M |
| 5 |
State Street
Boston,
Massachusetts
|
-$33.1M |